このアイテムのアクセス数: 7

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s12891-023-06185-4.pdf940.58 kBAdobe PDF見る/開く
タイトル: Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial
著者: Onishi, Akira  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-3120-1273 (unconfirmed)
Torii, Mie
Hidaka, Yu  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-3637-4429 (unconfirmed)
Uozumi, Ryuji
Oshima, Yohei
Tanaka, Hiroki
Onizawa, Hideo
Fujii, Takayuki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6556-1226 (unconfirmed)
Murata, Koichi  kyouindb  KAKEN_id
Murakami, Kosaku  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-5981-4648 (unconfirmed)
Tanaka, Masao  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-8942-2933 (unconfirmed)
Matsuda, Shuichi  kyouindb  KAKEN_id
Morinobu, Akio  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-4672-638X (unconfirmed)
Arai, Hidenori
Hashimoto, Motomu
著者名の別形: 大西, 輝
鳥井, 美江
日髙, 優
魚住, 龍史
大島, 洋平
田中, 浩基
鬼澤, 秀夫
藤井, 貴之
村田, 浩一
村上, 孝作
田中, 真生
松田, 秀一
森信, 暁雄
キーワード: Rheumatoid arthritis
Sarcopenia
Exercise
Randomized controlled trial
発行日: 11-Apr-2023
出版者: Springer Nature
BMC
誌名: BMC Musculoskeletal Disorders
巻: 24
論文番号: 280
抄録: [Background] Patients with rheumatoid arthritis (RA) are prone to muscle atrophy due to inflammatory cytokines and corticosteroid use and immobility due to joint pain and deformity. Although resistance training is effective and safe in reversing muscle atrophy in RA, some patients are unable to perform a conventional high-load exercise program due to disease-related limitations. This study aims to examine the efficacy of individualized exercise therapy on physical function in elderly patients with RA who are at a high risk for sarcopenia. [Methods] This study is a single-center, parallel-group, two-arm, healthcare provider- and outcome assessor-blinded, superiority randomized controlled trial with a 1:1 allocation ratio. A total of 160 participants with RA between 60 and 85 years of age with a positive screening test for sarcopenia will be included. The intervention group will receive nutritional guidance and a four-month individualized exercise program in addition to the usual treatment. The control group will receive nutritional guidance in addition to the usual care. The primary endpoint will be physical function assessed using the Short Physical Performance Battery (SPPB) at 4 months. The data on outcome measures will be collected at baseline and at the two- and four-month follow-ups. Linear mixed-effects models for repeated measures will be conducted using the modified intention-to-treat analysis population. [Discussion] This study will provide evidence on whether a personalized exercise program can improve physical function and quality of life in elderly patients with RA. Some limitations include limited generalizability due to the single-center study and lack of blinding of the patients to the intervention assignment because of the nature of the exercise. Physical therapists may use this knowledge in their daily practice to improve RA treatment. Tailored exercise may enhance the health outcomes of the RA population and contribute to a reduction in healthcare costs. [Trial registration] The study protocol was retrospectively registered at the University hospital Medical Information Network-Clinical Trial Repository (UMIN-CTR) (registration number: UMIN000044930, https://www.umin.ac.jp/ctr/index-j.htm) on January 4, 2022.
著作権等: © The Author(s) 2023
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
URI: http://hdl.handle.net/2433/294498
DOI(出版社版): 10.1186/s12891-023-06185-4
PubMed ID: 37041556
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons